Page 5 - Pharma Mar News Today

Shares in Spanish pharmaceutical company PharmaMar spiked over 20% on Tuesday after it cited a paper published by peer-reviewed journal Science that confirmed "potent preclinical efficacy" of its drug Aplidin against COVID-19.

The UCSF-led team racing to find a COVID cure may have found a promising candidate FacebookTwitterEmail 1of3 Aplidium albicans is a marine invertebrate that lives off the shores of a tiny, uninhabited island in the Mediterranean Sea.Courtesy of Pharma MarShow MoreShow Less 2of3 Aplidium albicans — a type of “sea squirt” found near Es Vedrà off the coast of Ibiza. (Photo by Andres Iglesias/Getty Images)Andres Iglesias / Getty ImagesShow MoreShow Less 3of3 Aplidium albicans — a type of ...

New COVID-19 therapy could be 30 times more potent than Remdesivir FacebookTwitterEmail File photo of the drug Remdesivir, an antiviral medication that has been used to treat patients with COVID-19.Ulrich Perrey/afp/TNS A UCSF-led science team may have found another breakthrough drug treatment to fight COVID-19, as first reported by the San Francisco Chronicle. Studies have shown that small concentrations of Aplidin, a drug created using an extraction from a marine creature called Aplidium albi...

Share this article Share this article ResearchAndMarkets.coms offering. The global multiple myeloma drugs market grew at a CAGR of around 9% during 2014-2019. Multiple myeloma, or Kahlers disease, refers to a form of blood cancer that primarily affects the plasma cells. Some of the most common types of multiple myeloma drugs include chemotherapeutic agents, corticosteroids and immunomodulatory agents. These pharmaceutical drugs aid in promoting bone healing, prevent hypercalcemia, bone fractur...